Ozempic and metformin lower blood sugar by roughly the same amount, but they work differently, cost vastly different amounts, and shine in different clinical situations. In separate trials, Ozempic reduced HbA1c by 1.4 to 1.6% over 30 weeks, while metformin reduced it by about 1.4% over 29 weeks. Neither is universally “better.” The right choice depends on your health profile, your weight goals, and what you can afford.
How They Lower Blood Sugar
Metformin and Ozempic attack high blood sugar from completely different angles. Metformin works primarily in the liver, reducing the amount of sugar it dumps into your bloodstream between meals. It also helps your muscles and fat cells respond more effectively to insulin. You take it as a pill, usually twice a day.
Ozempic (semaglutide) mimics a gut hormone called GLP-1 that your body naturally releases after eating. It signals your pancreas to produce more insulin when blood sugar is high, slows down how quickly food leaves your stomach, and acts on appetite centers in the brain to reduce hunger. It’s a once-weekly injection you give yourself with a pen.
Weight Loss: Ozempic’s Biggest Edge
This is where the two medications diverge most. Ozempic produces significantly more weight loss than metformin because it directly suppresses appetite and slows digestion. In clinical trials for type 2 diabetes, people on Ozempic typically lose 8 to 14 pounds over the course of treatment, with higher doses producing greater loss. Metformin can help with modest weight loss or at least prevent weight gain, but the effect is far smaller, often in the range of 2 to 6 pounds.
If excess weight is a central part of your diabetes picture, or if you’re trying to avoid medications that cause weight gain (like certain insulins), Ozempic offers a clear advantage. That appetite-reducing effect is also why semaglutide, the active ingredient in Ozempic, became the basis for the weight-loss drug Wegovy.
Heart, Kidney, and Liver Benefits
The 2025 guidelines from the American Diabetes Association specifically recommend GLP-1 receptor agonists like Ozempic over metformin in several situations where organ protection matters. If you have established heart disease or are at high risk for it, current standards call for a GLP-1 medication to reduce cardiovascular events, regardless of your blood sugar numbers. The same applies if you have chronic kidney disease with reduced kidney function, heart failure with preserved pumping ability and obesity, or fatty liver disease tied to metabolic problems.
For people with advanced kidney disease (filtration rate below 30), Ozempic is preferred for another practical reason: metformin must be stopped at that level of kidney function because it can build up to dangerous levels. Metformin requires dose reduction once kidney filtration drops below 45, and it’s contraindicated below 30. Ozempic doesn’t carry those same kidney-related restrictions.
Side Effects and Tolerability
Both medications cause gastrointestinal problems, especially early on. Nausea, diarrhea, bloating, and indigestion are common with each. But the severity differs. Metformin’s side effects tend to be milder and often resolve on their own over a few weeks, or can be managed by taking the medication with food. The extended-release version of metformin further reduces stomach issues.
Ozempic’s gastrointestinal side effects are generally harder to manage. Nausea and vomiting can be persistent, particularly during dose increases. Some people also experience constipation. These effects do improve for most people over time, but the adjustment period can be rougher than with metformin.
One side effect unique to long-term metformin use is vitamin B12 depletion. About 30% of people on metformin for extended periods develop some degree of B12 malabsorption, and the drug can lower B12 levels by 14 to 30%. Low B12 can cause fatigue, numbness in your hands and feet, and cognitive changes. If you’ve been on metformin for years, periodic B12 testing is worthwhile.
Cost: A Deciding Factor for Many
Metformin is one of the cheapest diabetes medications available. As a generic drug that’s been around for decades, it typically costs under $10 to $20 per month, even without insurance. Most pharmacy discount programs cover it, and virtually every insurance plan includes it at the lowest copay tier.
Ozempic is dramatically more expensive. Without insurance, a month’s supply runs roughly $900 to $1,000. Insurance coverage varies widely. Some plans cover it with a specialty copay; others require prior authorization proving that metformin alone wasn’t sufficient. If cost or coverage is a barrier, this price gap alone may determine which medication is realistic for you.
When Each Medication Is the Better Choice
Metformin remains the standard first-line treatment for most people newly diagnosed with type 2 diabetes who primarily need blood sugar control. It’s effective, well-tolerated, inexpensive, and has decades of safety data behind it. For someone whose main goal is getting HbA1c into a healthy range without other complicating health conditions, metformin is a perfectly reasonable starting point.
Ozempic becomes the stronger option when blood sugar control is only part of the picture. The ADA guidelines favor it when any of the following apply:
- Cardiovascular disease or high cardiovascular risk, where Ozempic has demonstrated benefits in reducing heart attacks and strokes
- Significant weight loss needed, since its appetite-suppressing effects far exceed metformin’s
- Chronic kidney disease, particularly at stages where metformin must be reduced or stopped
- Heart failure with obesity, where it can reduce heart-failure-related symptoms
- Metabolic fatty liver disease, where GLP-1 medications show potential benefits
Using Both Together
This isn’t always an either/or decision. Many people take both medications at the same time. A common treatment path starts with metformin, and if blood sugar stays above target, Ozempic gets added on. The two drugs work through different mechanisms, so their effects stack. Combining them doesn’t increase gastrointestinal side effects beyond what each would cause on its own, based on data from the American Diabetes Association showing that adding a GLP-1 medication to existing metformin use doesn’t worsen gut symptoms during the adjustment period.
If your doctor suggests combining both, the rationale is straightforward: metformin handles baseline liver sugar output and insulin sensitivity at minimal cost, while Ozempic adds appetite control, additional blood sugar lowering, and organ-protective benefits that metformin doesn’t offer.